Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01729741
Other study ID # Rec Ref 2010-139
Secondary ID
Status Completed
Phase N/A
First received November 14, 2012
Last updated November 19, 2012
Start date December 2010
Est. completion date April 2011

Study information

Verified date December 2010
Source Makerere University
Contact n/a
Is FDA regulated No
Health authority Uganda: Research Ethics Committee
Study type Interventional

Clinical Trial Summary

Thyroidectomy is one of the most commonly performed operations in general surgery. Available data seem to suggest an association between no-drain usage and a shorter duration of hospital stay. Seung et al found that the (following thyroidectomy) time to discharge after thyroidectomy was significantly shorter in the no drain group compared to the drain group. Similar results were recorded in a study conducted by Davari et al. Hyoung et al reported the incidence of hematoma formation post- thyroidectomy to be varying between 0.3%-4.3%. Tahsin et al reported that post-thyroidectomy bleeding is as rare as 0.3%-1.0%. The fear of an hematoma enlarging and obstructing the airway and causing difficulty in breathing, prompts many surgeons to use drains routinely after any type of thyroid surgery. The main reason is to drain off a possible postoperative hemorrhage, which may compress the airway and produce respiratory fail


Description:

This study will be aimed at comparing the patient outcomes with drain and no-drain insertion methods after thyroidectomy in a resource limited setting.

Study population: All adult patients aged between 18 to 79 years who attended the endocrinology outpatient clinic and had been diagnosed with goiter.

Study Participants: All adult patients with goiters who were eligible for thyroidectomy Inclusion criteria: All adult patients aged between 18 to 79 years with a diagnosis of goiter who consented to participate in the study.

Exclusion criteria: The investigators excluded patients with goiter who had a history suggestive of bleeding tendencies, recurrent goiter, and thyroid cancer with fixation of the thyroid gland to surrounding structures and had uncontrolled co-morbidities such as diabetes mellitus (DM) and hypertension (HT).

Inserting a drain after goiter surgery and not inserting a drain is the intervention all participants receive the same treatment


Recruitment information / eligibility

Status Completed
Enrollment 68
Est. completion date April 2011
Est. primary completion date April 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 79 Years
Eligibility Inclusion Criteria:

- All adult patients aged between 18 to 79 years with a diagnosis of goiter who consented to participate in the study

Exclusion Criteria:

- We excluded patients with goiter who had a history suggestive of bleeding tendencies, recurrent goiter, and thyroid cancer with fixation of the thyroid gland to surrounding structures and had uncontrolled co-morbidities such as diabetes mellitus (DM) and hypertension (HT).

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Intervention

Procedure:
drain was inserted after thyroid surgery
insertion of drain after thyroid surgery

Locations

Country Name City State
Uganda Makerere University Kampala
Uganda Mulago Hospital Kampala

Sponsors (2)

Lead Sponsor Collaborator
Makerere University Department of Surgery

Country where clinical trial is conducted

Uganda, 

References & Publications (1)

Khanna J, Mohil RS, Chintamani, Bhatnagar D, Mittal MK, Sahoo M, Mehrotra M. Is the routine drainage after surgery for thyroid necessary? A prospective randomized clinical study [ISRCTN63623153]. BMC Surg. 2005 May 19;5:11. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other wound sepsis post operative wound infection 7 days Yes
Primary Duration of hospital stay Duration of hospital stay 7 days Yes
Secondary Haematoma formation post operative complication 7 days Yes
See also
  Status Clinical Trial Phase
Completed NCT04062175 - Efficacy of Adding Azithromycin to Cephalosporin Before Cesarean Delivery Phase 4